Propofol anesthesia and molecular changes in the brain

2022 ◽  
pp. 57-66
Author(s):  
Desanka Milanović ◽  
Željko Pavković ◽  
Vesna Pešić
Keyword(s):  
Author(s):  
Kathryn J. Reissner ◽  
Peter W. Kalivas

Exposure to drugs of abuse can be a reinforcing experience that, in vulnerable individuals, can lead to continued use and the development of an addiction disorder. Evidence indicates that the escalation in use and compulsive motivation to obtain the drug is linked to long-lasting cellular changes within the brain reward neurocircuitry. In this chapter we describe the stages of transition in use from social use to habitual relapse, and within that context we describe the implicated neurocircuitry, and the enduring cellular and molecular changes that occur within that circuitry, that may mediate the preoccupation with drug seeking in addiction-vulnerable individuals.


Author(s):  
Kathryn J. Reissner ◽  
Peter W. Kalivas

Exposure to drugs of abuse is for most individuals a reinforcing experience which can lead to continued use and the development of an addiction disorder. Evidence indicates that the escalation in use and ultimately compulsive motivation to obtain drug is linked to long lasting cellular changes within the brain reward neurocircuitry. In this chapter we will describe the transition in use from isolated social use to habitual relapse, and within that context will describe the neurocircuitry implicated in this process and the enduring cellular and molecular changes which occur within that circuitry that may mediate preoccupation with drug seeking in the addiction vulnerable individual.


2009 ◽  
Vol 30 (8) ◽  
pp. 1259-1275 ◽  
Author(s):  
Yoshinori Masuo ◽  
Tsunehiko Imai ◽  
Junko Shibato ◽  
Misato Hirano ◽  
Oliver A. H. Jones ◽  
...  

Cells ◽  
2020 ◽  
Vol 9 (4) ◽  
pp. 1026 ◽  
Author(s):  
Ahmad Raza Khan ◽  
Lili Geiger ◽  
Ove Wiborg ◽  
Boldizsár Czéh

Major depressive disorder (MDD) is a severe illness imposing an increasing social and economic burden worldwide. Numerous rodent models have been developed to investigate the pathophysiology of MDD. One of the best characterized and most widely used models is the chronic mild stress (CMS) model which was developed more than 30 years ago by Paul Willner. More than 2000 published studies used this model, mainly to assess novel compounds with potential antidepressant efficacy. Most of these studies examined the behavioral consequences of stress and concomitant drug intervention. Much fewer studies focused on the CMS-induced neurobiological changes. However, the stress-induced cellular and molecular changes are important as they may serve as potential translational biomarkers and increase our understanding of the pathophysiology of MDD. Here, we summarize current knowledge on the structural and molecular alterations in the brain that have been described using the CMS model. We discuss the latest neuroimaging and postmortem histopathological data as well as molecular changes including recent findings on microRNA levels. Different chronic stress paradigms occasionally deliver dissimilar findings, but the available experimental data provide convincing evidence that the CMS model has a high translational value. Future studies examining the neurobiological changes in the CMS model in combination with clinically effective antidepressant drug intervention will likely deliver further valuable information on the pathophysiology of MDD.


Sign in / Sign up

Export Citation Format

Share Document